Butterfield, Lisa H.
Funding for this research was provided by:
National Institutes of Health (P50 CA121973, P30 CA047904)
National Cancer Institute (R01 CA138635, R01 104524)
Article History
Received: 2 September 2015
Accepted: 21 January 2016
First Online: 3 February 2016
Compliance of ethical standard
:
: Lisa H. Butterfield is co-inventor of patents covering aspects of alpha-fetoprotein as a target for T cell-mediated anti-hepatocellular cancer immunity.